SWOG clinical trial number
SWOG-8093
Treatment of Metastatic Malignant Mesothelioma: A Comparison of Cyclophosphamide, DTIC and Adriamycin (CIA) versus Cyclophosphamide and Adriamycin (CA) (Intergroup Mesothelioma Study II)
Closed
Phase
Published
Abbreviated Title
Treatment of Metastatic Malignant Mesothelioma: A Comparison of Cyclophosphamide, DTIC and Adriamycin (CIA) versus Cyclophosphamide and Adriamycin (CA) (Intergroup Mesothelioma Study II)
Activated
05/20/1981
Closed
10/03/1984
Publication Information Expand/Collapse
1987
Randomized comparison of cyclophosphamide, imidazole carboxamide,and adriamycin, versus cyclophosphamide and adriamycin in patientswith advanced stage malignant mesothelioma: A Sarcoma IntergroupStudy.
1985
Randomized comparison of cyclophosphamide, DTIC, and Adriamycin (CIA) vs. Cyclophosphamide and Adriamycin (CA) in malignant mesothelioma: A sarcoma intergroup study.